Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FCN
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 41.25 2.46 1.74
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 393.30 1.88 -0.38
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.42 58.73 56.79
Cash -25.96 6.97 9.42
Capex 26.01 -0.13 -0.18
Free Cash Flow -26.01 -7.99 10.80
Revenue 0.17 26.55 26.50
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.42 0.32 0.34
Operating Margin -13.74 0.11 0.12
ROA -2.00 0.02 0.02
ROE -5.52 0.04 0.04
ROIC -14.24 0.03 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FCN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FCN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FCN is permitted for members.